Par Health USA, LLC recalls Buprenorphine Hydrochloride
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Crystallization
- Products
-
- Buprenorphine Hydrochloride
- Company
- Par Health USA, LLC
- Where it was sold
-
U.S. Nationwide
Nationwide
- Units affected
- 154210 bottles
- About this recall
- Buprenorphine Hydrochloride, Injection 0.3 mg/mL, Rx Only, 5 x 1 mL Single Dose Vials, Manufactured for: Endo USA, Malvern, PA, NDC 42023-179-05